Medical and Pharmaceutical BioMark expands lung cancer screening portfolio with patented urine test It is one of a select few pursuing this variety of diagnostics Rowan DunneJune 10, 2026
Medical and Pharmaceutical AI-powered blood test promises lung cancer detection 5 years in advance British scientists used the biopsy to detect a 14-protein blood signature linked to the disease Rowan DunneJune 4, 2026
Sleep Resmed tackles restless legs syndrome with Noctrix Health takeover Respiratory disorders are no longer the sleep tech company's only focus Rowan DunneJune 3, 2026
Medical and Pharmaceutical Guardant gets FDA nod for next-gen cancer mutation blood test Milestone builds on firm attaining FDA Breakthrough Device Designation for another liquid biopsy in 2025 Rowan DunneMay 24, 2026
Medical and Pharmaceutical Laurexa Capital closes €520M fundraising to propel European medtech The funds were pooled together in only 1.5 years Rowan DunneMay 20, 2026
Medical and Pharmaceutical PrognomiQ shares promising early results from novel lung cancer blood test Promising, but the findings are derived from a small study Rowan DunneMay 13, 2026
Medical and Pharmaceutical Malaysia’s new ‘Lungshield’ programme is screening 10,000 local traffic cops They have been identified as a high-risk group Rowan DunneMay 10, 2026
Medical and Pharmaceutical Virtual reality headset company XRHealth wins medtech innovation award Therapeutic content for veterans is one of the company's specialities Rowan DunneMay 8, 2026
Medical and Pharmaceutical Abbott’s coronary imaging tech gets regulatory wins with FDA clearance, CE mark It helps doctors fix blocked heart arteries efficiently Rowan DunneMay 4, 2026
Medical and Pharmaceutical Ohio’s ‘Breath of Hope’ Gala raises money for lung cancer research The event has generated over US$1.6 million since 2015 Rowan DunneApril 30, 2026